Eli Lilly and Company Stock News
$789.32
4.55%
yesterday
NYSE,
Nov 26, 10:15 pm CET
Eli Lilly and Company Stock News
Positive
The Motley Fool
●
13 days ago
These are income stocks you can buy and hold forever.
marktEINBLICKE
●
13 days ago
Der dänische Insulin-Weltmarktführer Novo Nordisk konnte einige Sorgen in Bezug auf die Wachstumsaussichten bei Abnehmmedikamenten ausräumen.
Neutral
PRNewsWire
●
13 days ago
SURMOUNT-1 results show a 94% reduction in risk of progression to type 2 diabetes across all pooled doses of tirzepatide compared to placebo over three years Results suggest one new case of diabetes could be prevented for every nine patients treated with tirzepatide Participants treated with tirzepatide had an average weight reduction of 22.9% (15 mg dose) INDIANAPOLIS , Nov. 13, 2024 /PRNewswi...
Positive
Reuters
●
13 days ago
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections.
Neutral
Business Wire
●
13 days ago
CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics Selected as Recipient of ALS Association's Barnett Grant, Disarm Therapeutics' founders Drs. Milbrandt & DiAntonio to join Asha SAB.
Positive
The Motley Fool
●
14 days ago
If Wall Street's right, investors will get a lot more than just rising dividend payments from this pair.
Neutral
The Motley Fool
●
16 days ago
Conditions are getting a bit more challenging for the drugmaker.
Neutral
The Motley Fool
●
17 days ago
The good times aren't over, but the peak of the party might be passing.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
